Literature DB >> 23152183

DRESS syndrome and thrombotic thrombocytopaenic purpura: are they related?

Zahrae Sandouk1, Zaid Alirhayim, Dania Khoulani, Syed Hassan.   

Abstract

A middle-aged man diagnosed with a drug reaction with eosinophilia and systemic symptom (DRESS) syndrome, secondary to phenytoin use, subsequently developed thrombotic thrombocytopaenic purpura. The patient improved with steroids and plasmapheresis. Their diagnosis can be challenging, and an early recognition and treatment are critical owing to their high mortality rates. Both diseases are thought to be of an autoimmune origin, and a potential relationship between them led to the consideration of the DRESS syndrome as an aetiology for thrombotic thrombocytopaenic purpura in this case. We concluded that two possibilities exist: some type of antibody developed during the clinical presentation of DRESS syndrome and subsequently resulted in an inhibition of a disintegrin and metalloproteinase with a thrombospondin type-1 motif, member 13 (ADAMTS13) leading to thrombotic thrombocytopaenic purpura, or perhaps this patient's autoimmune predisposition to thrombotic thrombocytopaenic purpura contributed to the drug reaction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152183      PMCID: PMC4543742          DOI: 10.1136/bcr-2012-007558

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

Review 1.  Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

Authors:  William F Clark
Journal:  Semin Dial       Date:  2012-02-07       Impact factor: 3.455

Review 2.  Recognition and management of severe cutaneous drug reactions.

Authors:  Sandra R Knowles; Neil H Shear
Journal:  Dermatol Clin       Date:  2007-04       Impact factor: 3.478

Review 3.  Thrombotic thrombocytopenic purpura: recognition and management.

Authors:  Joseph E Kiss
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

Review 4.  Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts.

Authors:  Paulo Ricardo Criado; Roberta Fachini Jardim Criado; João de Magalhães Avancini; Claudia Giuli Santi
Journal:  An Bras Dermatol       Date:  2012 May-Jun       Impact factor: 1.896

Review 5.  Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking.

Authors:  S A Walsh; D Creamer
Journal:  Clin Exp Dermatol       Date:  2011-01       Impact factor: 3.470

6.  Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases.

Authors:  Yi-Chun Chen; Hsien-Ching Chiu; Chia-Yu Chu
Journal:  Arch Dermatol       Date:  2010-08-16

Review 7.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

8.  Allopurinol-induced recurrent DRESS syndrome: pathophysiology and treatment.

Authors:  Rima Shalom; Sofia Rimbroth; Dganit Rozenman; Arie Markel
Journal:  Ren Fail       Date:  2008       Impact factor: 2.606

9.  DRESS syndrome associated with carbamazepine and phenytoin.

Authors:  Jean-Pierre Allam; Teresa Paus; Christoph Reichel; Thomas Bieber; Natalija Novak
Journal:  Eur J Dermatol       Date:  2004 Sep-Oct       Impact factor: 3.328

10.  Autoimmune disorders in patients with idiopathic thrombotic thrombocytopenic purpura.

Authors:  M-L John; I Scharrer
Journal:  Hamostaseologie       Date:  2012       Impact factor: 1.778

  10 in total
  4 in total

Review 1.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

2.  DRESS syndrome with thrombotic microangiopathy revealing a Noonan syndrome: Case report.

Authors:  Mickaël Bobot; Matteo Coen; Clémentine Simon; Laurent Daniel; Gilbert Habib; Jacques Serratrice
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

3.  Co-Occurrence of Multiple Endocrine Abnormalities Induced by the DIHS/DRESS.

Authors:  Mingqun Deng; Han Wu; Miao Yu; Yi Tian; Yuxiu Li; Xinhua Xiao
Journal:  Int J Endocrinol       Date:  2019-10-03       Impact factor: 3.257

4.  Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course.

Authors:  José Thiago de Souza de Castro; Simone Appenzeller; Marina Pereira Colella; Gabriela Yamaguti-Hayakawa; Erich Vinícius De Paula; Joyce Annichinno-Bizzachi; Fernando Cendes; Reis Fabiano; Fernanda Andrade Orsi
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.